PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Use of low-dose neostigmine intravenously in the treatment of thyroid storm-induced severe tachycardia in patient during huge pelvic mass resection: A case report and review of literature.

Abstract Thyroid storm is a rare and life-threatening metabolic crisis because of an emergent release of excess thyroid hormone. Sinus tachycardia induced by excess thyroid hormone may result in congestive heart failure due to decreased diastolic filling time.
PMID
Related Publications

Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.

Impending thyroid storm in a pregnant woman with undiagnosed hyperthyroidism: A case report and literature review.

Anesthetic management using esmolol for arthroscopic synovectomy in a patient with thyroid storm.

Failure of esmolol to control tachycardia associated with thyroid storm after subtotal thyroidectomy.

High dose neostigmine treatment of malignant sinus tachycardia.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 29620652
OWN - NLM
STAT- MEDLINE
DCOM- 20180416
LR  - 20180425
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 14
DP  - 2018 Apr
TI  - Use of low-dose neostigmine intravenously in the treatment of thyroid
      storm-induced severe tachycardia in patient during huge pelvic mass resection: A 
      case report and review of literature.
PG  - e0300
LID - 10.1097/MD.0000000000010300 [doi]
AB  - RATIONALE: Thyroid storm is a rare and life-threatening metabolic crisis because 
      of an emergent release of excess thyroid hormone. Sinus tachycardia induced by
      excess thyroid hormone may result in congestive heart failure due to decreased
      diastolic filling time. PATIENT CONCERNS: A controlled hyperthyroidism patient
      with severe sinus tachycardia. DIAGNOSES: A controlled hyperthyroidism patient
      was induced thyroid storm during huge pelvic mass resection. INTERVENTIONS:
      Application of low-dose neostigmine and beta-antagonist esmolol to control the
      heart rate (HR) avoided hemodynamic collapse. OUTCOMES: The patient improved
      dramatically following application of low-dose neostigmine instead of esmolol to 
      control the HR avoided hemodynamic collapse. LESSONS: Our case suggests that
      neostigmine, an acetylcholinesterase inhibitor, may warrant further investigation
      in patients with thyroid storm-induced severe sinus tachycardia.
FAU - Zhang, Xue
AU  - Zhang X
AD  - Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong
      University of Science and Technology, Wuhan, China.
FAU - Jiang, Hui
AU  - Jiang H
FAU - Li, Shiyong
AU  - Li S
FAU - Luo, Ailin
AU  - Luo A
FAU - Zhao, Yilin
AU  - Zhao Y
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Adrenergic beta-1 Receptor Antagonists)
RN  - 0 (Cholinesterase Inhibitors)
RN  - 0 (Propanolamines)
RN  - 3982TWQ96G (Neostigmine)
RN  - MDY902UXSR (esmolol)
SB  - AIM
SB  - IM
MH  - Administration, Intravenous
MH  - Adrenergic beta-1 Receptor Antagonists/administration & dosage
MH  - Adult
MH  - Cholinesterase Inhibitors/*administration & dosage
MH  - Female
MH  - Humans
MH  - Intraoperative Complications/*drug therapy/etiology
MH  - Neostigmine/*administration & dosage
MH  - Pelvic Neoplasms/surgery
MH  - Propanolamines/administration & dosage
MH  - Surgical Procedures, Operative/adverse effects
MH  - Tachycardia/*drug therapy/etiology
MH  - Thyroid Crisis/complications/*drug therapy
PMC - PMC5902261
EDAT- 2018/04/06 06:00
MHDA- 2018/04/17 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/17 06:00 [medline]
AID - 10.1097/MD.0000000000010300 [doi]
AID - 00005792-201804060-00030 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2018 Apr;97(14):e0300. doi: 10.1097/MD.0000000000010300.